Majority of women with early-stage breast cancer in U.S. eceive unnecessarily long courses of radiation

Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study. "Hypofractionated radiation is infrequently used for women with early-stage breast cancer, even though it's high-quality, patient-centric cancer care at lower cost," said the study's lead author. "It is clinically equivalent to longer duration radiation in curing breast cancer, has similar side effects, is more convenient for patients, and allows patients to return to work or home sooner."

Read the whole article on Science Daily

More from Science Daily